Thermo Fisher Scientific

Molecular testing content for clinical lab professionals and clinicians

  • Categories
    • Science and education
    • Product news
    • Case studies
    • Perspectives
    • Events
    • News

Mark Stevenson, Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific announces…

Clinical Conversation blog - home icon Product news 1 mins. Sharing ▼ Details ▼
  • Linked In sharing icon
  • Facebook sharing icon
  • Twitter sharing icon
  • Email sharing icon
12 Apr 2021 || By Manoj Gandhi Shares: 0 Versions of this article Original article. Tags COVID-19, High-throughput, Sars-cov-2

the US FDA’s Emergency Use Authorization for the Amplitude™ Solution

The FDA has issued emergency use authorization for Thermo Fisher Scientific’s Amplitude Solution. “We are grateful for our partners and have scaled resources to bring supplies that you need,” says Mark Stevenson, Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific, the world’s leader in serving science.

The Amplitude™ Solution brings a dynamic and world-class COVID-19 testing system to labs to test between 1,000 and 8,000 samples per day with minimal laboratory resources and 24/7 dedicated support. According to Mr. Stevenson, Amplitude is critically important in the next phase of the ongoing fight against COVID-19 as many resume pre-COVID behaviors and practices. One of the ways to help manage the re-opening of the world’s economies will be through comprehensive testing for COVID-19. The SARS-CoV-2 virus is pervasive and elusive, and we may witness upcoming waves during the fall flu season, with the on-going emergence of mutations and other seasonal respiratory diseases. For these reasons, we continue to scale our innovations around responding to this crisis and helping you meet your clinical testing needs.

Thank you for your partnership and extraordinary commitment to clinical excellence.

For Emergency Use Authorization (EUA) only. For prescription use only. For in vitro diagnostic use.

Privacy StatementTerms & ConditionsLocationsSitemap

© 2022 Thermo Fisher Scientific. All Rights Reserved.

Home > Product news > Mark Stevenson, Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific announces…

Talk to us